Technical Analysis for AXSM - Axsome Therapeutics, Inc.

Grade Last Price % Change Price Change
F 29.72 4.17% 1.19
AXSM closed up 4.17 percent on Friday, September 17, 2021, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up
Historical AXSM trend table...

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Stochastic Reached Overbought Strength 0.00%
Weak + Overbought Other 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 4.17%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 4.17%
Wide Bands Range Expansion 4.17%
1,2,3 Retracement Bearish Bearish Swing Setup 7.22%
Older End-of-Day Signals for AXSM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High about 22 hours ago
Up 3% about 22 hours ago
Possible Inside Day about 23 hours ago
Up 2% about 24 hours ago
60 Minute Opening Range Breakout 1 day ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, develops therapies for the management and treatment of pain and other central nervous system disorders. Its product candidates include AXS-02, which is in Phase III trial for the treatment of pain in patients with complex regional pain syndrome; and AXS-05 for the treatment of agitation in patients with Alzheimer's disease and treatment resistant depression. The company is also developing AXS-02 for the treatment of knee osteoarthritis and chronic low back pain, as well as a preclinical development program AXS-06 for the treatment of chronic pain disorders. Axsome Therapeutics, Inc. was founded in 2012 and is based in New York, New York.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Development Pain Organ Systems Alzheimer's Disease Chronic Pain Pain Management Nervous System Disorders Central Nervous System Disorders Osteoarthritis Knee Depression Perception Treatment Of Chronic Pain Antidepressants Chronic Condition Back Pain Treatment Resistant Depression

Is AXSM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 87.24
52 Week Low 19.38
Average Volume 1,461,716
200-Day Moving Average 59.86
50-Day Moving Average 37.47
20-Day Moving Average 26.10
10-Day Moving Average 27.34
Average True Range 2.23
ADX 32.47
+DI 20.77
-DI 21.44
Chandelier Exit (Long, 3 ATRs) 23.11
Chandelier Exit (Short, 3 ATRs) 26.06
Upper Bollinger Bands 29.83
Lower Bollinger Band 22.36
Percent B (%b) 0.99
BandWidth 28.63
MACD Line -1.94
MACD Signal Line -3.34
MACD Histogram 1.4006
Fundamentals Value
Market Cap 1.11 Billion
Num Shares 37.3 Million
EPS -1.37
Price-to-Earnings (P/E) Ratio -21.63
Price-to-Sales 0.00
Price-to-Book 19.73
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 32.71
Resistance 3 (R3) 32.40 31.09 32.21
Resistance 2 (R2) 31.09 30.33 31.25 32.04
Resistance 1 (R1) 30.41 29.86 30.75 30.72 31.88
Pivot Point 29.10 29.10 29.28 29.26 29.10
Support 1 (S1) 28.42 28.34 28.76 28.73 27.56
Support 2 (S2) 27.11 27.87 27.27 27.40
Support 3 (S3) 26.43 27.11 27.23
Support 4 (S4) 26.74